Multiple and Concomitant Molecular Findings in a Heavily Treated Patient With EGFR-positive Lung Cancer

被引：0
|
作者：
Citarella, Fabrizio [1 ]
Russano, Marco [1 ]
Galletti, Alessandro [1 ]
Vincenzi, Bruno [1 ]
Tonini, Giuseppe [1 ]
Santini, Daniele [1 ]
机构：
[1] Univ Campus Biomed Roma, Dept Med Oncol, Via Alvaro Portillo 200, I-00128 Rome, Italy
来源：
CLINICAL LUNG CANCER | 2021年 / 22卷 / 02期
关键词：
D O I：
10.1016/j.cllc.2020.09.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：137 / 138
页数：2
相关论文
共 50 条
  • [1] Advanced lung adenocarcinoma in an EGFR-positive patient treated with Erlotinib for 52 months
    Goncalves, Ivone
    Ladeira, Ines
    Castro, Ana
    Antunes, Ana
    Barroso, Ana
    Parente, Barbara
    RESPIRATORY MEDICINE CASE REPORTS, 2013, 10 : 10 - 12
  • [2] Black pleural effusion in a patient with EGFR-positive lung adenocarcinoma
    Issaris, Vasileios
    Kotsifas, Konstantinos
    Lazarou, Vasiliki
    Giosdekou, Natalia
    Poupouzas, Georgios
    Athanasiou, Nikolaos
    Giannikos, Georgios
    Kompogiorgas, Steven
    Milas, Gerasimos-Panagiotis
    Balis, Evangelos
    PNEUMON, 2023,
  • [3] Treatment Patterns in Patients With EGFR-Positive Lung Cancer: A Real-World Patient-Report
    Elkins, I.
    Feldman, J.
    Figueras, A.
    Kennedy, T.
    King-Kallimanis, B.
    Roy, U.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S900 - S900
  • [4] Patient Age and EGFR-positive Non-small Cell Lung Cancer: A Multicenter Retrospective Study
    Maezawa, Yosuke
    Taguchi, Manato
    Kawakami, Takeshi
    Inui, Toshihide
    Okauchi, Shinichiro
    Numata, Takeshi
    Shiozawa, Toshihiro
    Miyazaki, Kunihiko
    Nakamura, Ryota
    Iguchi, Kesato
    Endo, Takeo
    Sakamoto, Tohru
    Satoh, Hiroaki
    Hizawa, Nobuyuki
    ANTICANCER RESEARCH, 2024, 44 (04) : 1751 - 1757
  • [5] Hyponatremia in a 58-year-old female patient with EGFR-positive lung adenocarcinoma
    Koch, M.
    Utpatel, K.
    Schulz, C.
    INTERNIST, 2018, 59 (04): : 384 - 387
  • [6] AFATINIB FOR THE TREATMENT OF PATIENTS WITH EGFR-POSITIVE NON-SMALL CELL LUNG CANCER
    Bowles, D. W.
    Weickhardt, A.
    Jimeno, A.
    DRUGS OF TODAY, 2013, 49 (09) : 523 - 535
  • [7] Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticles
    Qian, Yichun
    Qiu, Mantang
    Wu, Qingquan
    Tian, Yanyan
    Zhang, Yu
    Gu, Ning
    Li, Suyi
    Xu, Lin
    Yin, Rong
    SCIENTIFIC REPORTS, 2014, 4
  • [8] Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticles
    Yichun Qian
    Mantang Qiu
    Qingquan Wu
    Yanyan Tian
    Yu Zhang
    Ning Gu
    Suyi Li
    Lin Xu
    Rong Yin
    Scientific Reports, 4
  • [9] A macrocyclic kinase inhibitor overcomes triple resistant mutations in EGFR-positive lung cancer
    Mai Suzuki
    Ken Uchibori
    Tomoko Oh-hara
    Yumi Nomura
    Ryusei Suzuki
    Ai Takemoto
    Mitsugu Araki
    Shigeyuki Matsumoto
    Yukari Sagae
    Mutsuko Kukimoto-Niino
    Yusuke Kawase
    Mikako Shirouzu
    Yasushi Okuno
    Makoto Nishio
    Naoya Fujita
    Ryohei Katayama
    npj Precision Oncology, 8
  • [10] A macrocyclic kinase inhibitor overcomes triple resistant mutations in EGFR-positive lung cancer
    Suzuki, Mai
    Uchibori, Ken
    Oh-hara, Tomoko
    Nomura, Yumi
    Suzuki, Ryusei
    Takemoto, Ai
    Araki, Mitsugu
    Matsumoto, Shigeyuki
    Sagae, Yukari
    Kukimoto-Niino, Mutsuko
    Kawase, Yusuke
    Shirouzu, Mikako
    Okuno, Yasushi
    Nishio, Makoto
    Fujita, Naoya
    Katayama, Ryohei
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
12345